Crossmark Global Holdings, Inc. Bristol Myers Squibb CO Transaction History
Crossmark Global Holdings, Inc.
- $6.02 Billion
- Q2 2025
A detailed history of Crossmark Global Holdings, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 228,026 shares of BMY stock, worth $9.89 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
228,026
Previous 216,452
5.35%
Holding current value
$9.89 Million
Previous $13.2 Million
20.04%
% of portfolio
0.18%
Previous 0.24%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...